Resources

A CONTINUOUS SCIENTIFIC OUTPUT

As a leading CRO in biosafety testing based on NGS assays for viral safety and genetic characterization at a GMP grade, PathoQuest is committed to share scientific researches and data evidence on its portfolio of assays.

Our experts in genome sequencing, virology and bioinformatics are continuously aiming to issue scientific overviews of our NGS QC biosafety assays.

  • Evaluation of a viral transcriptome Next Generation Sequencing assay as an alternative to animal assays for viral safety testing of cell substrates
Pascale Beurdeley-Fehlbaum 1Matthew Pennington 2Nicolas Hégerlé 1Mélanie Albert 1Amy Bennett 3Justine Cheval 1Allison Clark 3Stéphane Cruveiller 1Céline Desbrousses 1Janalyn Frederick 4Edwige Gros 1Kathryn Hunter 3Tareq Jaber 3Madison Gaiser 5Ophélie Jouffroy 1Arnaud Lamamy 1Mickael Melkowski 1Jennifer Moro 3Paula Niksa 3Shenba Pillai 3Marc Eloit 6Horst Ruppach 3

2023 Aug

    • Adventitious Virus Detection in Cells by High-Throughput Sequencing of Newly Synthesized RNAs: Unambiguous Differentiation of Cell Infection from Carryover of Viral Nucleic Acids

2019 May-Jun

    • Use of a new RNA next generation sequencing approach for the specific detection of virus infection in cells
Audrey Brussel 1Kerstin Brack 2Erika Muth 3Rudolf Zirwes 3Justine Cheval 3Charles Hebert 3Jean-Marie Charpin 3Alice Marinaci 2Benoit Flan 1Horst Ruppach 2Pascale Beurdeley 3Marc Eloit 4

2019 May

    • Viral metagenomics and blood safety
V Sauvage 1, M Eloit 2

2016 Feb

    • The potential of whole genome NGS for infectious disease diagnosis
Marc Lecuit 1Marc Eloit 2 3

2015 Nov

    • Analysis by high throughput sequencing of Specific Pathogen Free eggs

2014 Jul

    • The diagnosis of infectious diseases by whole genome next generation sequencing: a new era is opening
Marc Lecuit 1Marc Eloit 2

2014 Mar

Integration Site Analysis (ISA) Assay - Oct 2023

Name(Required)
This field is for validation purposes and should be left unchanged.

Genetic Characterization of Gene Therapy Vectors & Vaccines by Next Generation Sequencing (NGS) - May 2023

  • This field is for validation purposes and should be left unchanged.

New ICHQ5A Guideline Adoption
Nov 2023

Contact us

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

E: contact@pathoquest.com

Sign up for our latest news

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

E: contact@pathoquest.com

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

Sign up for our latest news